Catalent
CTLT
#1834
Rank
โ‚น1.087 T
Marketcap
โ‚น5,992
Share price
0.00%
Change (1 day)
25.67%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น597.46. In 2023 the company made an earnings per share (EPS) of -โ‚น641.82 a decrease over its 2022 EPS that were of โ‚น214.25.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-17.86%
2023-โ‚น641.82-399.56%
2022โ‚น214.25-30.58%
2021โ‚น308.6479.67%
2020โ‚น171.78114.12%
2019โ‚น80.23-15%
2018โ‚น94.3975.44%
2017โ‚น53.80-22.97%
2016โ‚น69.84-59.56%
2015โ‚น172.72282.05%
2014โ‚น45.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น64.18-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น43.42-107.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น70.79-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น139.69-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA